Author:
Chang Jenny C.,Makris Andreas,Gutierrez M. Carolina,Hilsenbeck Susan G.,Hackett James R.,Jeong Jennie,Liu Mei-Lan,Baker Joffre,Clark-Langone Kim,Baehner Frederick L.,Sexton Krsytal,Mohsin Syed,Gray Tara,Alvarez Laura,Chamness Gary C.,Osborne C. Kent,Shak Steven
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. EBCTG (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942
2. The Early Breast Cancer Trialists’ Collaborative Group E (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351(9114):1451–1467
3. Hortobagyi G (1997) Docetaxel in combined modality therapy for breast cancer. Oncology 11(6):9–10
4. Henderson IC, Berry D, Demetri G et al. (1998) Improved disease free survival and overall survival from the addition of sequential paclitaxel but not from escalation of doxorubicin in the adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc Am Soc Clin Onco 17:101
5. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16(8):2672–2685
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献